N/A
Completed N=327
Community-Based, Client-Centered Prevention Homes to Address the Rural Opioid Epidemic- Aim 3
Source: ClinicalTrials.gov NCT04268173 ↗Enrolled (actual)
327
Serious AEs
0.0%
Results posted
Aug 2024
Primary outcomePrimary: Change in the Addiction Treatment Accessibility and Utilization as Assessed by Change in Likert Scale — 1.26; 1.07; 1.12; 1.03 score on a scale — p=0.84
Summary
The goal of this study was to effectively use a client-centered community-based intervention to engage people who inject drugs (PWIDs) in healthcare that helps reduce risky behaviors and lower infectious disease risks. Participants in the intervention group of this study received a 12-week intensive multilevel harm reduction case-management intervention at three rural Vivent Health offices. Service coordination aimed to reduce human immunodeficiency virus (HIV), hepatitis C virus (HCV), and overdose risks in PWIDs. Prevention Navigators (PNs) at each office helped to coordinate referrals to reduce substance use disorder and increase engagement in the substance use disorder care cascades.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in the Addiction Treatment Accessibility and Utilization as Assessed by Change in Likert Scale |
1.26; 1.07; 1.12; 1.03 | 0.84 |
| PRIMARY Change in the Addiction Treatment Accessibility and Utilization as Assessed by Change in Frequency of "Yes" Answers |
0.17; 0.16; 0.037; 0.11 | — |
| PRIMARY Change in the Risk of HIV as Assessed by Change in Likert Scale |
1.05; 1.09; 1.28; 0.86 | — |
| PRIMARY Change in the Risk of HIV as Assessed by Risky Behavior Frequencies |
0.24; 0.25; 0.19; 0.21 | — |
| PRIMARY Change in the Risk of Drug Overdose as Assessed by Change in Likert Scale |
0.52; 0.42; 0.57; 0.56 | — |
Eligibility Criteria
Inclusion Criteria
- has injected drugs in the past 30 days, resides in Wisconsin, over 18 years of age
- able to read and write in English
Exclusion Criteria
-
Data sourced from ClinicalTrials.gov (NCT04268173). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.